We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRWD:NASDAQCrowdStrike Holdings, Inc. Analysis

Data as of 2026-03-27 - not real-time

$392.62

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CrowdStrike remains a high‑growth cybersecurity play, but its market price is far above intrinsic estimates. The stock trades below its short‑term moving averages, the RSI sits in the low‑forties and the MACD histogram is negative, signaling a bearish technical backdrop. Meanwhile, the forward P/E is more than double the industry average and the DCF fair‑value estimate is well under the current price, suggesting the equity is overvalued at present.
On the fundamental side, revenue is expanding at a robust double‑digit rate and the company holds a strong cash position with minimal debt, providing a solid financial cushion. However, profitability remains negative, margins are thin and free cash flow, while positive, is modest relative to the market cap. Recent news highlights a short‑term outperformance versus the broader market and heightened investor interest driven by AI‑related hype, but the broader software‑infrastructure sector faces elevated competitive and regulatory pressures.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and price below short‑term moving averages
  • Decreasing volume trend
  • Current price significantly above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and high gross margin
  • Robust cash balance with low debt
  • Valuation premium remains wide despite improving fundamentals

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Recurring subscription model with expanding AI‑driven security offerings
  • Large addressable market and leadership in endpoint protection
  • Solid free cash flow generation supporting future strategic investments

Key Metrics & Analysis

Financial Health

Revenue Growth23.30%
Profit Margin-3.38%
P/E Ratio63.6
ROE-4.14%
ROA-1.57%
Debt/Equity18.34
P/B Ratio22.5
Op. Cash Flow$1.6B
Free Cash Flow$1.6B
Industry P/E32.6

Technical Analysis

TrendBearish
RSI41.4
Support$359.29
Resistance$452.00
MA 20$416.09
MA 50$419.98
MA 200$466.18
MACDBearish
VolumeDecreasing
Fear & Greed Index72.43

Valuation

Fair Value$236.65
Target Price$490.48
Upside/Downside24.92%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.40
Volatility57.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.